Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng C Ngu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Gastroenterology|January 21, 2022
Reflux scintigraphy in gastro-esophageal reflux disease: a comparison study with 24 hour pH-impedance monitoringLisa S E Shim, Meng C Ngu, Yunki Yau, et al.
Internal Medicine Journal|June 13, 2018
Utility of minimal preparation computed tomography colonography in detecting colorectal cancer in elderly and frail patientsDavid J Meiklejohn, Lloyd J Ridley, Meng C Ngu, et al.
Journal of Gastroenterology and Hepatology|May 12, 2011
Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath testGordon J-H Park, Elke Wiseman, Jacob George, et al.
Nature Reviews. Gastroenterology & Hepatology|July 28, 2025
Liver, ageing and diseaseDavid G Le Couteur, Meng C Ngu, Nicholas J Hunt, et al.
Journal of Clinical Gastroenterology|July 28, 2010
Hypophosphataemic osteomalacia in patients on adefovir dipivoxilChristian M Girgis, Tang Wong, Meng C Ngu, et al.
Journal of Gastroenterology and Hepatology|August 9, 2007
Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis BDavid van der Poorten, Emilia Prakoso, Teh-Liane Khoo, et al.
Ageing Research Reviews|January 30, 2026
Ageing and Liver Immune CellsJarrod J Kennedy, Patrick Bertolino, Sophie Lucic Fisher, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
The Journal of Infectious Diseases|September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling PathwaysSamuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapySimon J Hume, Danny K Wong, Man-Fung Yuen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Gastroenterology|January 21, 2022
Reflux scintigraphy in gastro-esophageal reflux disease: a comparison study with 24 hour pH-impedance monitoringLisa S E Shim, Meng C Ngu, Yunki Yau, et al.
Internal Medicine Journal|June 13, 2018
Utility of minimal preparation computed tomography colonography in detecting colorectal cancer in elderly and frail patientsDavid J Meiklejohn, Lloyd J Ridley, Meng C Ngu, et al.
Journal of Gastroenterology and Hepatology|May 12, 2011
Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath testGordon J-H Park, Elke Wiseman, Jacob George, et al.
Nature Reviews. Gastroenterology & Hepatology|July 28, 2025
Liver, ageing and diseaseDavid G Le Couteur, Meng C Ngu, Nicholas J Hunt, et al.
Journal of Clinical Gastroenterology|July 28, 2010
Hypophosphataemic osteomalacia in patients on adefovir dipivoxilChristian M Girgis, Tang Wong, Meng C Ngu, et al.
Journal of Gastroenterology and Hepatology|August 9, 2007
Combination adefovir-lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis BDavid van der Poorten, Emilia Prakoso, Teh-Liane Khoo, et al.
Ageing Research Reviews|January 30, 2026
Ageing and Liver Immune CellsJarrod J Kennedy, Patrick Bertolino, Sophie Lucic Fisher, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
The Journal of Infectious Diseases|September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling PathwaysSamuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapySimon J Hume, Danny K Wong, Man-Fung Yuen, et al.
Pageof 2